Uppsala, 7 June 2026 Probingon AB announces that a new peer-reviewed study validating the FAT-IBC platform has been published in Scientific Reports, a Nature Portfolio journal. The paper, authored by researchers at Uppsala University’s Microwaves in Medical Engineering Group, demonstrates
Read MoreUppsala, 2 June 2026 Probingon AB announces that Fat Intrabody Communication (FAT-IBC), the company’s core platform technology, has been selected by the Royal Swedish Academy of Engineering Sciences (IVA) for their 2026 List for Research Impact. The IVA List recognises Swedish research
Read MoreUppsala, Sweden – 2024-07-26 A significant step forward in personalized healthcare is being made possible with Eurostars funding for the further development of the DIAMPS project. This consortium, commercially led by Probingon AB, is creating a novel, handheld muscle-sensing device that
Read MoreI am very pleased to announce that we have a new board member joining our company as of March 27, 2023. Johan Lidén will become a welcome addition to our board of directors. Johan brings to the board 40 years of experience within all important phases of the Medical Device business, having
Read More